The Board of Directors of Mindesta Inc. announced the appointment of Dr. Stephen Houldsworth to it's advisory board of CTT Pharmaceuticals effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.034 USD | -13.04% | -15.00% | +21.43% |
2020 | CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech | CI |
2020 | CTT Pharmaceutical Holdings, Inc. Announces Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
+21.43% | 1.96M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- CTTH Stock
- News CTT Pharmaceutical Holdings, Inc.
- Dr. Stephen Houldsworth, Pharma Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board